United States · FDA National Drug Code directory

Divalproex Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68788-8609_9b32cb32-87e3-43dc-ae3b-cc7f5296310d
Product NDC: 68788-8609
Form: TABLET, DELAYED RELEASE
Composition / generic term: Divalproex Sodium
Labeler: Preferred Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20250328
Source listing expiry: 20271231

Source-listed ingredients

DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8609-3) · 68788-8609-3
60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8609-6) · 68788-8609-6
90 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8609-9) · 68788-8609-9

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →